Connect with us


Fed report on cannabis legalization benefits & costs (Newsletter: October 18, 2023)



Jersey City suit on police marijuana use; Colombian president smells cannabis in NYC; CA gov signs marijuana bills; Lubbock, TX decrim

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Get our daily newsletter.

Your support makes Marijuana Moment possible…

Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.

  • Kween Brooke: “I’m a psychiatric nurse practitioner from Ohio, and I offer medication management and psychotherapy services to patients of all ages. I’m excited to pledge my support to you because your information is extremely valuable to me when it comes to advocating for my patients. Thanks for all that you do!”

Support our work at


A new report published by the Federal Reserve Bank of Kansas City details the “broadly distributed” economic benefits of legalizing marijuana—such as increases in state income, housing prices and population—but also the social costs that are “more concentrated among individuals.”

Jersey City, New Jersey officials are suing the state in federal court because they want to maintain the ability to fire police officers for using marijuana—but the complaint seems to ignore a key provision of federal firearms law.

Colombian President Gustavo Petro said he smelled marijuana “on all the streets” during a recent visit to New York City, citing the “enormous hypocrisy” of legal cannabis sales now taking place in the nation that launched the global war on drugs decades ago.

California Gov. Gavin Newsom (D) signed bills on marijuana business licensing changes, distribution of fines collected from illicit operations and membership of a state cannabis task force.

Lubbock, Texas activists turned in what they believe are more than enough signatures to qualify a marijuana decriminalization initiative for the local ballot if the City Council doesn’t enact it first.

Former Arkansas lawmakers are on opposing sides of new litigation alleging fraud in medical cannabis licensing.

A poll from the New Hampshire Cannabis Association found that 78 percent of farmers in the state are interested in growing marijuana if it is legalized—but that only 11 percent support Gov. Chris Sununu’s (R) plan to conduct sales through state-run stores.


Rep. Glenn Ivey (D-MD) spoke during a hearing about mass incarceration driven by jailing people for everything from “marijuana on up.”


Oregon Gov. Tina Kotek (D) said she thinks the state’s voter-approved drug decriminalization law “needs some fixes,” including on the issue of public use.

The Missouri legislature’s Joint Committee on Administrative Rules will hold a hearing on marijuana packaging, product and labeling rules on Wednesday.

The Massachusetts Cannabis Control Commission appointed an acting executive director.

Oklahoma regulators filed revised medical cannabis rules.

New York regulators extended the deadline for the current round of marijuana business license applications.

Minnesota generated $1.5 million in revenue from hemp-derived THC edibles in the first two months of a new tax on sales.

Colorado regulators are hiring a psychedelics policy advisor.

Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.


Boulder County, Colorado officials are being sued by a marijuana business that says a misinterpretation of a settlement with another company is blocking its expansion plans.


A Canadian judge upheld Manitoba’s ban on marijuana home cultivation.


A study found that “cannabis products attenuated oxaliplatin-induced peripheral neuropathy.”

A review concluded that “clinical phase I-II trials published to date reported promising results for psilocybin in the treatment of patients with major depressive disorder and treatment-resistant depression, in a relatively short time after administration.”


Psychedelics researcher Roland Griffiths passed away.

The Cannabis Council of Canada issued recommendations for changes to the country’s marijuana policies.


4Front Ventures Corp. entered into a $10 million senior secured credit facility agreement.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Get our daily newsletter.

Photo by Aphiwat chuangchoem.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Become a patron at Patreon!

Tom Angell is the editor of Marijuana Moment. A 20-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he founded the nonprofit Marijuana Majority. Previously he reported for and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.


Marijuana News In Your Inbox

Get our daily newsletter.

Support Marijuana Moment

Marijuana News In Your Inbox


Get our daily newsletter.